These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 22751750)
1. Targeting of the anti-apoptotic gene survivin in human thyroid carcinoma. Chen Z; Liu N; Zhu G; Dralle H; Hoang-Vu C Int J Mol Med; 2012 Sep; 30(3):465-72. PubMed ID: 22751750 [TBL] [Abstract][Full Text] [Related]
2. CD82, and CD63 in thyroid cancer. Chen Z; Mustafa T; Trojanowicz B; Brauckhoff M; Gimm O; Schmutzler C; Köhrle J; Holzhausen HJ; Kehlen A; Klonisch T; Finke R; Dralle H; Hoang-Vu C Int J Mol Med; 2004 Oct; 14(4):517-27. PubMed ID: 15375577 [TBL] [Abstract][Full Text] [Related]
3. Role of survivin in the pathogenesis of papillary thyroid carcinoma. Li JY; Shi J; Sang JF; Yao YZ; Wang XC; Su L Genet Mol Res; 2015 Nov; 14(4):15102-11. PubMed ID: 26634473 [TBL] [Abstract][Full Text] [Related]
4. Nicotinamide phosphorybosiltransferase overexpression in thyroid malignancies and its correlation with tumor stage and with survivin/survivin DEx3 expression. Sawicka-Gutaj N; Waligórska-Stachura J; Andrusiewicz M; Biczysko M; Sowiński J; Skrobisz J; Ruchała M Tumour Biol; 2015 Sep; 36(10):7859-63. PubMed ID: 25946974 [TBL] [Abstract][Full Text] [Related]
5. The role of survivin in thyroid tumors: differences of expression in well-differentiated, non-well-differentiated, and anaplastic thyroid cancers. Pannone G; Santoro A; Pasquali D; Zamparese R; Mattoni M; Russo G; Landriscina M; Piscazzi A; Toti P; Cignarelli M; Lo Muzio L; Bufo P Thyroid; 2014 Mar; 24(3):511-9. PubMed ID: 24117205 [TBL] [Abstract][Full Text] [Related]
6. [Expression of survivin gene in thyroid carcinoma and its significance]. Xiang C; Liu WS; Jia SS Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1761-3. PubMed ID: 17919384 [TBL] [Abstract][Full Text] [Related]
7. Survivin delta Ex3 overexpression in thyroid malignancies. Waligórska-Stachura J; Andrusiewicz M; Sawicka-Gutaj N; Biczysko M; Jankowska A; Kubiczak M; Czarnywojtek A; Wrotkowska E; Ruchała M PLoS One; 2014; 9(6):e100534. PubMed ID: 24945990 [TBL] [Abstract][Full Text] [Related]
8. Changes in the expression pattern of apoptotic molecules (galectin-3, Bcl-2, Bax, survivin) during progression of thyroid malignancy and their clinical significance. Selemetjev SA; Savin SB; Paunovic IR; Tatic SB; Cvejic D Wien Klin Wochenschr; 2015 May; 127(9-10):337-44. PubMed ID: 25471003 [TBL] [Abstract][Full Text] [Related]
9. Concomitant high expression of survivin and vascular endothelial growth factor-C is strongly associated with metastatic status of lymph nodes in papillary thyroid carcinoma. Selemetjev S; Savin S; Paunovic I; Tatic S; Cvejic D J Cancer Res Ther; 2018; 14(Supplement):S114-S119. PubMed ID: 29578160 [TBL] [Abstract][Full Text] [Related]
10. Expression of telomerase genes in thyroid carcinoma. Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of survivin expression and its prognostic value in papillary thyroid carcinoma. Selemetjev S; Dencic TI; Marecko I; Jankovic J; Paunovic I; Savin S; Cvejic D Pathol Res Pract; 2014 Jan; 210(1):30-4. PubMed ID: 24199968 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of skin squamous cell carcinoma proliferation and promote apoptosis by dual silencing of NET-1 and survivin. Ji ZJ; Wang JL; Chen L Oncol Rep; 2015 Aug; 34(2):811-22. PubMed ID: 26080853 [TBL] [Abstract][Full Text] [Related]
13. ABCG2/BCRP gene expression is related to epithelial-mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1). Mato E; González C; Moral A; Pérez JI; Bell O; Lerma E; de Leiva A J Mol Endocrinol; 2014 Jun; 52(3):289-300. PubMed ID: 24643400 [TBL] [Abstract][Full Text] [Related]
14. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features]. Jiang XL; Zhang H; Chen YL; Peng L Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755 [No Abstract] [Full Text] [Related]
15. Survivin regulates the expression of VEGF-C in lymphatic metastasis of breast cancer. Cai X; Ma S; Gu M; Zu C; Qu W; Zheng X Diagn Pathol; 2012 May; 7():52. PubMed ID: 22607367 [TBL] [Abstract][Full Text] [Related]
16. Expression, regulation and function of autotaxin in thyroid carcinomas. Kehlen A; Englert N; Seifert A; Klonisch T; Dralle H; Langner J; Hoang-Vu C Int J Cancer; 2004 May; 109(6):833-8. PubMed ID: 15027116 [TBL] [Abstract][Full Text] [Related]
17. Modulatory role of miR-205 in angiogenesis and progression of thyroid cancer. Salajegheh A; Vosgha H; Md Rahman A; Amin M; Smith RA; Lam AK J Mol Endocrinol; 2015 Dec; 55(3):183-96. PubMed ID: 26342107 [TBL] [Abstract][Full Text] [Related]
18. Transcription factor Runx2 is a regulator of epithelial-mesenchymal transition and invasion in thyroid carcinomas. Niu DF; Kondo T; Nakazawa T; Oishi N; Kawasaki T; Mochizuki K; Yamane T; Katoh R Lab Invest; 2012 Aug; 92(8):1181-90. PubMed ID: 22641097 [TBL] [Abstract][Full Text] [Related]
19. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance. Su L; Wang Y; Xiao M; Lin Y; Yu L Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995 [TBL] [Abstract][Full Text] [Related]
20. Survivin-deltaEx3: a novel biomarker for diagnosis of papillary thyroid carcinoma. Vandghanooni S; Eskandani M; Montazeri V; Halimi M; Babaei E; Feizi MA J Cancer Res Ther; 2011; 7(3):325-30. PubMed ID: 22044815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]